Bonner Michael 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Apr 17, 2020
Insider Transaction Report
Form 4
Bonner Michael
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2020-03-18$3.53/sh−2,134$7,533→ 17,787 total - Award
Common Stock
2020-03-23$3.56/sh+2,500$8,900→ 20,287 total
Footnotes (2)
- [F1]This transaction represents shares purchased by the Company to cover the tax withholding obligations for the vesting of shares.
- [F2]Restricted stock award will vest 100% on March 23, 2024.